Skip to main content
رجوع
Watch Compare

BICYCLE THERAPEUTICS PLC

جودة البيانات: 100%
BCYC
Nasdaq Manufacturing Chemicals
KWD 4.93
▼ KWD 0.05 (-1.00%)
القيمة السوقية: 343.66 M
السعر
KWD 4.93
القيمة السوقية
343.66 M
نطاق اليوم
KWD 4.91 — KWD 5.01
نطاق 52 أسبوعًا
KWD 4.24 — KWD 9.55
حجم التداول
184,401
فتح KWD 4.95
متوسط 50 يوم / 200 يوم
KWD 5.40
8.70% below
متوسط 50 يوم / 200 يوم
KWD 6.88
28.36% below

Quick Summary

النقاط الرئيسية

Revenue grew 57.83% annually over 5 years — strong growth
Negative free cash flow of -252.03 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 47.94%
Capital efficient — spends only 3.24% of revenue on capex

النمو

Revenue Growth (5Y)
57.83%
أعلى من متوسط القطاع (9.35%)
Revenue (1Y)105.77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-34.02%
أعلى من متوسط القطاع (-51.02%)
ROIC-26.93%
Net Margin-301.66%
Op. Margin-340.38%

الأمان

Debt / Equity
N/A
Current Ratio10.66
Interest Coverage-1199.34

التقييم

PE (TTM)
-1.57
أعلى من متوسط القطاع (-1.98)
P/B Ratio0.56
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -1.6 -2.0
P/B 0.6 5.1
ROE % -34.0 -51.0
Net Margin % -301.7 -150.2
Rev Growth 5Y % 57.8 9.3
D/E — 0.3

ETFs Holding This Stock

MEDX logo MEDX Horizon Kinetics Medical ETF
0.62% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 105.77% Revenue Growth (3Y) 64.04%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 57.83% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 72.59 M Net Income (TTM) -218.96 M
ROE -34.02% ROA -27.44%
Gross Margin N/A Operating Margin -340.38%
Net Margin -301.66% Free Cash Flow (TTM) -252.03 M
ROIC -26.93% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 10.66
Interest Coverage -1199.34 Asset Turnover 0.09
Working Capital 669.54 M Tangible Book Value 618.48 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.57 Forward P/E N/A
P/B Ratio 0.56 P/S Ratio 4.73
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -73.34%
Market Cap 343.66 M Enterprise Value -304.67 M
Per Share
EPS (Diluted TTM) -3.16 Revenue / Share 1.04
FCF / Share -3.62 OCF / Share -3.58
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 3.24% FCF Conversion 115.10%
SBC-Adj. FCF -289.04 M Growth Momentum 47.94

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 72.59 M 35.28 M 26.98 M 14.46 M 11.70 M
Net Income -218.96 M -169.03 M -180.66 M -112.72 M -66.82 M
EPS (Diluted) -3.16 -2.90 -5.08 -3.80 -2.67
Gross Profit — — — — —
Operating Income -247.07 M -209.87 M -189.95 M -116.65 M -65.62 M
EBITDA — — — — —
R&D Expenses 240.28 M 172.97 M 156.50 M 81.61 M 44.88 M
SG&A Expenses — — — — —
D&A 6.42 M 7.17 M 6.55 M 3.69 M 1.41 M
Interest Expense 206,000.0 1.73 M 3.26 M 3.34 M 2.98 M
Income Tax 152,000.0 -4.77 M 1.46 M -1.52 M -1.66 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 717.60 M 956.87 M 595.34 M 410.61 M 479.79 M
Total Liabilities 107.62 M 163.81 M 224.41 M 139.83 M 133.54 M
Shareholders' Equity 609.98 M 793.06 M 370.93 M 270.78 M 346.25 M
Total Debt — 30.70 M 30.70 M 30.32 M 29.87 M
Cash & Equivalents 628.11 M 879.52 M 526.42 M 339.15 M 438.70 M
Current Assets 682.89 M 928.61 M 561.87 M 369.38 M 458.56 M
Current Liabilities 56.98 M 67.23 M 69.54 M 53.34 M 36.24 M